Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-12-051516
Filing Date
2012-09-14
Accepted
2012-09-14 16:38:15
Documents
5
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v323647_10ka.htm 10-K/A 1176143
2 EXHIBIT 31.1 v323647_ex31-1.htm EX-31.1 9349
3 EXHIBIT 31.2 v323647_ex31-2.htm EX-31.2 9245
4 EXHIBIT 32.1 v323647_ex32-1.htm EX-32.1 4558
5 EXHIBIT 32.2 v323647_ex32-2.htm EX-32.2 4603
  Complete submission text file 0001144204-12-051516.txt   1204985
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 001-15697 | Film No.: 121093008
SIC: 2834 Pharmaceutical Preparations